Cerebral ischaemia and matrix metalloproteinase-9 modulate the angiogenic function of early and late outgrowth endothelial progenitor cells

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 12, 2013, Pages 1543-1553

  Morancho, Anna ^a   Hernández Guillamon, Mar ^a   Boada, Cristina ^a   Barceló, Verónica ^a   Giralt, Dolors ^a   Ortega, Laura ^a   Montaner, Joan ^a   Rosell, Anna ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Angiogenesis; Cerebral ischaemia; Endothelial progenitor cell; Matrix metalloproteinase 9; Neurorepair; Stroke

Indexed keywords

ANIMALIA; MUS;

COLLAGEN; GELATINASE B; LAMININ; MATRIGEL; MATRIX METALLOPROTEINASE INHIBITOR; PROTEOGLYCAN;

ANGIOGENESIS; ANIMAL; ARTICLE; BRAIN ISCHEMIA; CELL COUNT; CEREBROVASCULAR ACCIDENT; DRUG COMBINATION; DRUG EFFECT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYMOLOGY; HUMAN; IMMUNOPHENOTYPING; MALE; MATRIX METALLOPROTEINASE-9; METABOLISM; MOUSE; NEUROREPAIR; PATHOLOGY; PATHOPHYSIOLOGY; STEM CELL;

ANGIOGENESIS; CEREBRAL ISCHAEMIA; ENDOTHELIAL PROGENITOR CELL; MATRIX METALLOPROTEINASE-9; NEUROREPAIR; STROKE;

ANIMALS; BRAIN ISCHEMIA; CELL COUNT; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; HUMANS; IMMUNOPHENOTYPING; LAMININ; MALE; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; STEM CELLS;

EID: 84891145231     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12116     Document Type: Article

References (37)

1. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359: 1317-29.
2. Carmichael ST. Themes and strategies for studying the biology of stroke recovery in the poststroke epoch. Stroke. 2008; 39: 1380-8.
3. Ohab JJ, Fleming S, Blesch A, et al. A neurovascular niche for neurogenesis after stroke. J Neurosci. 2006; 26: 13007-16.
4. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-7.
5. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999; 5: 434-8.
6. Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001; 108: 391-7.
7. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004; 24: 288-93.
8. Akita T, Murohara T, Ikeda H, et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest. 2003; 83: 65-73.
9. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004; 104: 2752-60.
10. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA. 2000; 97: 3422-7.
11. + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004; 114: 330-8.
12. Fan Y, Shen F, Frenzel T, et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol. 2010; 67: 488-97.
13. Moubarik C, Guillet B, Youssef B, et al. Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke. Stem Cell Rev. 2011; 7: 208-20.
14. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 2001; 21: 1104-17.
15. Johnson C, Sung HJ, Lessner SM, et al. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ Res. 2004; 94: 262-8.
16. Collen A, Hanemaaijer R, Lupu F, et al. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood. 2003; 101: 1810-7.
17. Rosell A, Lo EH. Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol. 2008; 8: 82-9.
18. Heo JH, Lucero J, Abumiya T, et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab. 1999; 19: 624-33.
19. Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke. 2001; 32: 1759-66.
20. Lee SR, Tsuji K, Lee SR, et al. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci. 2004; 24: 671-8.
21. Zhao BQ, Wang S, Kim HY, et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med. 2006; 12: 441-5.
22. Vu TH, Shipley JM, Bergers G, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998; 93: 411-22.
23. Morancho A, Garcia-Bonilla L, Barcelo V, et al. A new method for focal transient cerebral ischaemia by distal compression of the middle cerebral artery. Neuropathol Appl Neurobiol. 2012; 38: 617-27.
24. Rosell A, Arai K, Lok J, et al. Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. J Cereb Blood Flow Metab. 2009; 29: 933-43.
25. Navarro-Sobrino M, Rosell A, Hernandez-Guillamon M, et al. Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvasc Res. 2010; 80: 317-23.
26. Cuadrado E, Rosell A, Borrell-Pages M, et al. Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia. J Cereb Blood Flow Metab. 2009; 29: 398-410.
27. Yip HK, Chang LT, Chang WN, et al. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke. 2008; 39: 69-74.
28. Ghani U, Shuaib A, Salam A, et al. Endothelial progenitor cells during cerebrovascular disease. Stroke. 2005; 36: 151-3.
29. Lau KK, Chan YH, Yiu KH, et al. Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension. J Hum Hypertens. 2007; 21: 445-51.
30. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002; 109: 625-37.
31. Gong Y, Fan Y, Hoover-Plow J. Plasminogen regulates stromal cell-derived factor-1/CXCR4-mediated hematopoietic stem cell mobilization by activation of matrix metalloproteinase-9. Arterioscler Thromb Vasc Biol. 2011; 31: 2035-43.
32. Huang PH, Chen YH, Wang CH, et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2009; 29: 1179-84.
33. Somani A, Nguyen J, Milbauer LC, et al. The establishment of murine blood outgrowth endothelial cells and observations relevant to gene therapy. Transl Res. 2007; 150: 30-9.
34. Wei L, Fraser JL, Lu ZY, et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis. 2012; 46: 635-45.
35. Lindsey ML, Escobar GP, Dobrucki LW, et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006; 290: H232-9.
36. Hayashi T, Noshita N, Sugawara T, et al. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab. 2003; 23: 166-80.
37. Bagley RG, Weber W, Rouleau C, et al. Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy. Cancer Res. 2005; 65: 9741-50.